Former Starbucks CEO Howard Schultz steps down from coffee chain’s board

Former Starbucks CEO Howard Schultz steps down from coffee chain’s board


Former Starbucks CEO Howard Schultz speaks at the Annual Meeting of Shareholders in Seattle, March 22, 2017.

Jason Redmond | AFP | Getty Images

Former Starbucks CEO Howard Schultz is stepping down from the coffee chain’s board, the company said Wednesday.

“I look forward to supporting this next generation of leaders to steward Starbucks into the future as a customer, supporter and advocate in my role as chairman emeritus,” Schultz said in a statement.

The company said the change was part of a planned transition, but Schultz, 70, didn’t provide a reason for his exit.

His third stint as Starbucks’ chief executive ended in March, as Laxman Narasimhan stepped into the role. Schultz spent 11 months back in the top job. During that time, he crafted a strategy to modernize the company’s cafes, improve relations with its baristas and fuel further sales growth. He also spearheaded the launch of Starbucks Oleato, a line of olive oil-infused beverages.

But some of Schultz’s actions created new enemies. He took a more aggressive approach against baristas unionizing than Kevin Johnson, who took over as CEO after Schultz’s second stint. Starbucks Workers United and allies such as Sen. Bernie Sanders made billionaire Schultz the face of Starbucks’ anti-union stance. It culminated in Schultz being grilled in front of a Senate committee over the company’s alleged union busting shortly after he stepped down as chief executive.

Prior to his departure, Schultz told CNBC that he has no intention of taking the reins as CEO again.

Schultz previously stepped down from Starbucks’ board in June 2018 to prepare for a potential presidential run, before deciding against a bid. He had already handed off the CEO role to Johnson in 2017.

As Schultz departs the board, Wei Zhang will take his seat. Zhang served as a senior advisor to Alibaba and president of Alibaba Pictures Group.

Her experience with the Chinese e-commerce giant could aid Starbucks as it tries to help its Chinese business bounce back. China is Starbucks’ second-largest market, and some trends there, such as mobile ordering, have inspired changes to the company’s U.S. business.

Zhang also previously held roles at News Corp China, CNBC China, Bain and General Electric. She currently serves on Ralph Lauren’s board.

She is the third woman on Starbucks’ nine-person board, which includes chair Mellody Hobson and Land O’Lakes CEO Beth Ford.

Disclosure: CNBC China is an affiliate of CNBC.



Source

Nike cuts 1,400 roles in second round of layoffs this year
Business

Nike cuts 1,400 roles in second round of layoffs this year

People walk past a Nike store in New York City, on April 2, 2025. Kylie Cooper | Reuters Nike announced a new round of layoffs on Thursday impacting approximately 1,400 roles across the organization, mostly concentrated in its technology department. In a note from COO Venkatesh Alagirisamy, the company said the layoffs were part of […]

Read More
Trump administration moves to reclassify cannabis in major shift that could expand research
Business

Trump administration moves to reclassify cannabis in major shift that could expand research

The Trump administration moved Thursday to reclassify cannabis under federal law, which could significantly expand scientific research into the drug’s medical uses. The change would not legalize the drug at the federal level, but shift cannabis from its current status as a Schedule I substance to Schedule III under the U.S. Drug Enforcement Administration’s controlled […]

Read More
Regeneron inks drug pricing deal with Trump, will offer new hearing-loss therapy for free
Business

Regeneron inks drug pricing deal with Trump, will offer new hearing-loss therapy for free

U.S. President Donald Trump (C) speaks during an event on advancing health care affordability in the Oval Office of the White House on April 23, 2026 in Washington, DC. Alex Wong | Getty Images Regeneron agreed to lower U.S. drug prices for some Americans as part of a deal with President Donald Trump, the White […]

Read More